Drug
Danicamtiv clinical trials
Also written MYK-491 and BMS-986434.
Keep track of what changes. Save the danicamtiv studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2023 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 3 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Bristol-Myers Squibb (5) · Kardigan, Inc. (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses danicamtiv is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated CardiomyopathyRecruitingPhase 2/3Kardigan, Inc.NCT07210723Written as danicamtiv
- A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated CardiomyopathyRecruitingPhase 3Kardigan, Inc.NCT07771465Written as Danicamtiv
- Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other CausalitiesTerminatedPhase 2Bristol-Myers SquibbNCT04572893Written as danicamtiv
- A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05806359Written as Danicamtiv
- A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart FailureCompletedPhase 1Bristol-Myers SquibbNCT05952089Written as Danicamtiv
- A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT06027437Written as Danicamtiv
- v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491CompletedPhase 1/2Bristol-Myers SquibbNCT03447990Written as MYK-491
Given in every arm · 1 — danicamtiv is usual care beside what is tested
Codes
What other systems call danicamtiv · ClinicalTrials.gg INT002199
- MeSH (NLM) C000732026danicamtivOne source NLM
- UNII (FDA) 7B2CS922HIDANICAMTIVConfirmed FDA, NLM, Wikidata
- Wikidata Q123907335danicamtivConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C167013DanicamtivOne source FDA
- DrugBank DB18962One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000732026 | danicamtiv | One source NLM |
| UNII (FDA) | 7B2CS922HI | DANICAMTIV | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q123907335 | danicamtiv | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C167013 | Danicamtiv | One source FDA |
| DrugBank | DB18962 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.